Patent details

EP2558501 Title: MONOCLONAL ANTIBODIES AGAINST HER2 ANTIGENS, AND USES THEREFOR

Basic Information

Publication number:
EP2558501
PCT Application Number:
PCT/US/2011/032590
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP117161430
PCT Publication Number:
WO/2011/130580
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
MONOCLONAL ANTIBODIES AGAINST HER2 ANTIGENS, AND USES THEREFOR
French Title of Invention:
ANTICORPS MONOCLONAUX CONTRE ANTIGÈNES HER2 ET LEURS UTILISATIONS
German Title of Invention:
MONOKLONALE ANTIKÖRPER GEGEN HER2-ANTIGENE UND IHRE VERWENDUNG
SPC Number:

Dates

Filing date:
14/04/2011
Grant date:
07/09/2016
EP Publication Date:
07/09/2016
PCT Publication Date:
20/10/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
20/02/2013
EP B1 Publication Date:
07/09/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
14/04/2018
Expiration date:
14/04/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
14/04/2011
 
 

Name:
Alper Biotech LLC
Address:
9700 Great Seneca Highway Suite 188, Rockville, Maryland 20850, United States (US)

Inventor

Name:
ALPER Ozge
Address:
United States (US)

Priority

Priority Number:
324490 P
Priority Date:
15/04/2010
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 16/32;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
24/03/2017
Last Annual Fee Paid Number:
7
Last Annual Fee Paid Amount:
82 Euro
Payer:
MARKS & CLERK LLP
Filing date Document type Number of pages
30/08/2018 Outgoing Correspondence 1